Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nexalin TechnologyNXL +0.18%38 Pretax Margin % is -18,658.33% as of Jun. 2026. GuruFocus rates NXL with a GF Score™ of 38/100 and a GF Value™ of $0.66 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Nexalin Technology ranks worse than 96.81% on this metric.
The historical rank and industry rank for Nexalin Technology's Pretax Margin % or its related term are showing as below:
NXL'
s Pretax Margin % Range Over the Past 10 Years
Min: -4504.14 Med: -3455.24 Max: -128.54
Current: -4142.4
NXL's Pretax Margin % is ranked worse than 96.81% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 2.83
vs NXL: -4142.40
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Nexalin Technology Pretax Margin % Related Terms
Nexalin Technology Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Nexalin Technology's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NXL vs ICCM, ADGM, ALRTF: Pretax Margin % Comparison
For the Medical Devices subindustry, Nexalin Technology's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexalin Technology Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nexalin Technology's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Nexalin Technology's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexalin Technology (NXL) has a Pretax Margin % of -18,658.33% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Nexalin Technology and its competitors. According to the industry distribution chart, Nexalin Technology ranks #789 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 96.8%.
Is Nexalin Technology's Pretax Margin % too high?
Nexalin Technology's current Pretax Margin % is -18,658.33%. Based on the distribution chart, Nexalin Technology ranks #789 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nexalin Technology has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexalin Technology's Pretax Margin % compare to ICCM and ADGM?
According to the Medical Devices & Instruments industry distribution chart, Nexalin Technology ranks #789 out of 815 companies for Pretax Margin %. This places Nexalin Technology in the lower half of its industry. The industry median Pretax Margin % is 2.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.83, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Nexalin Technology and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexalin Technology's current Pretax Margin % is -18,658.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexalin Technology stock overvalued right now?
Based on GuruFocus' analysis, Nexalin Technology (NXL) is currently considered Possible Value Trap. The stock's GF Value™ is $0.66, compared to a current price of $0.33 — trading 49.6% below its estimated fair value. The current Pretax Margin % is -18,658.33%. Nexalin Technology's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Nexalin Technology (NXL), the current Pretax Margin % is -18,658.33% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexalin Technology (NXL) Overvalued in 2026?
Based on GuruFocus' analysis, Nexalin Technology stock appears to be undervalued.
The current stock price of $0.33 is trading 49.6% below its estimated GF Value™ of $0.66.
GuruFocus considers Nexalin Technology to be Possible Value Trap.
Key valuation signals for NXL:
Pretax Margin %: -18,658.33%
GF Value™: $0.66 vs. price of $0.33 (49.6% below fair value)
No single metric tells the full story. See the NXL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
38GF Score
Get the complete analysis for NXL
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NXL has been successfully added to your 
